Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine

This study has been completed.
Sponsor:
Collaborators:
European Union
Swedish Institute for Infectious Disease Control
Innogenetics
Information provided by (Responsible Party):
Institut National de la Santé Et de la Recherche Médicale, France
ClinicalTrials.gov Identifier:
NCT01188512
First received: August 24, 2010
Last updated: January 27, 2012
Last verified: January 2012